Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce (Author)
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : [U.S. Government Publishing Office], [2019]
Series:	Report / 116th Congress, 1st session, House of Representatives ; 116-46
Subjects:	Pharmaceutical industry > United States > Quality control. Generic drugs > Standards > United States. Generic drugs > Effectiveness > United States. Generic drugs > Prices. Drugs > United States > Cost effectiveness. Drugs > Cost effectiveness. Generic drugs > Standards. Pharmaceutical industry > Quality control. United States. Legislative materials.
Online Access:	PDF version Text version https://purl.fdlp.gov/GPO/gpo122825 https://purl.fdlp.gov/GPO/gpo122826

Description
Item Description:	"May 2, 2019."
Physical Description:	1 online resource (59 pages).
Bibliography:	Includes bibliographical references.